Private healthcare market may be anti-competitive with poor returns for patients

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2606 (Published 5 April 2012)
Cite this as: BMJ 2012;344:e2606

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Nigel Hawkes
  1. 1London

The Office of Fair Trading (OFT) has referred the private healthcare market to the Competition Commission, saying that it is not working properly for consumers. It warned last December that it intended to make the referral and the results of a public consultation since then have not changed its mind.

The OFT is critical of a lack of the information needed by consumers to make informed decisions and says that local monopolies and the ability of existing providers to make it difficult for new entrants to the market distort competition. As a result patients might pay higher prices than they need to or get poorer quality care.

In its market study, the OFT says that …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL